Richard Daniell, EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 257,970 shares at $32.36 ($8.3M) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Seasonal sale ($8.3M) by EVP, Europe Commercial — this insider has traded TEVA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.36 | 62,250 | $2.0M | 24.1% |
| 2 | $32.36 | 66,735 | $2.2M | 25.9% |
| 3 | $32.36 | 62,250 | $2.0M | 24.1% |
| 4 | $32.36 | 66,735 | $2.2M | 25.9% |
| Total | $32.36 avg | 257,970 | $8.3M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |
| TEVA | SELL | 2025-03-07 | $2.3M | — | Filing → |